Cytarabine
NDC 71288-168, Cytarabine, injection, solution, from Meitheal Pharmaceuticals Inc..
- Product NDC
- 71288-168
- Status
- Listed
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206190
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71288-168 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYTARABINE20 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71288-168-50 | 71288016850 | 1 VIAL, MULTI-DOSE in 1 CARTON (71288-168-50) / 50 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1be2668b-d76f-4c65-aea9-86c5c40889a2
Use it
Look up 71288-168 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71288-168 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71288-168. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.